Triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2-positive (HER2+) breast cancer metastasize and relapse earlier than hormone-dependent progesterone receptor-positive (PR+) and estrogen receptor-positive (ER+) breast cancers [5]. This evidence concerns the gene ERBB2 and breast carcinoma.